Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2011New England Journal of MedicineOpen Access

Long-Term Therapy with Bevacizumab in Hereditary Hemorrhagic Telangiectasia

View Full Paper
Ask AI
Bookmark
Share

Authors

BBBrian BrinkerhoffOregon Health & Science UniversityDPDavid M. PoetkerMedical College of WisconsinNCNicholas W. ChoongMayo Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brinkerhoff et al. (2011) studied this question.

synapsesocial.com/papers/6a9de41b36492d58faa61d77https://doi.org/10.1056/nejmc1012774
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bevacizumab in Hereditary Hemorrhagic Telangiectasia2009 · 121 citations
  2. 2Osteochondroma after total body irradiation: An age‐related complication2003 · 60 citations
  3. 3Osteochondroma after Hematopoietic Stem Cell Transplantation in Childhood. An Italian Study on Behalf of the AIEOP-HSCT Group2009 · 21 citations